This is a working overview of NAD+ biosynthesis, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-10-12. Anything still debated is marked as such rather than presented as settled.
Quality control for NMN materials usually covers identity, assay purity, residual solvents, heavy metals, microbial limits, and moisture content. Certificates of analysis from suppliers may report high-performance liquid chromatography purity, mass spectrometry identity, and elemental impurity testing. Regulatory treatment differs by country: NMN is not an approved drug, and its status as a dietary supplement ingredient or novel food has been debated. Some authorities have restricted sales pending safety and regulatory review, while others allow it under specific categories. Buyers should verify documentation rather than rely on label claims.
Quantifying NMN requires methods that separate it from structurally similar compounds such as nicotinamide, nicotinamide riboside, and NAD+. Common approaches include high-performance liquid chromatography coupled with ultraviolet detection, liquid chromatography with tandem mass spectrometry, capillary electrophoresis, and nuclear magnetic resonance for identity confirmation. Because NMN is polar and often present at low concentrations in biological samples, sample preparation can involve protein precipitation, solid-phase extraction, or derivatization. Isotope-labeled internal standards help correct for matrix effects and recovery losses. Reported concentrations depend heavily on the matrix, extraction protocol, and analytical platform.
Dietary sources of NMN include small amounts in certain vegetables, fruits, and other foods, although exact values vary by sample and method. Endogenous NMN concentrations are tightly regulated and often low, making measurement in blood or tissues technically demanding. After oral intake, NMN is thought to be rapidly metabolized in the intestine and liver, and intact NMN may not reach all tissues at high levels. Some rodent studies report increases in tissue NAD+ after oral NMN, while human data remain limited and sometimes rely on blood NAD+ metabolites rather than direct tissue measures.
Research on NMN has focused on aging, metabolic regulation, exercise capacity, and insulin sensitivity, but findings are preliminary. Many human trials are small, short in duration, and use different endpoints, which complicates comparison across studies. No national regulator has approved NMN as a therapeutic drug for any indication. In some countries it is sold as a supplement or research chemical, while other jurisdictions have questioned its status under food or supplement laws. Claims about extending human lifespan or reversing aging are not supported by established clinical evidence.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | −20 °C or below | Desiccated; amber container |
| Water solubility | Soluble | Polar; solution stability varies |
| Appearance | White to off-white powder | May be hygroscopic |
| Common analytical method | LC-MS/MS | Isotope-labeled internal standard often used |
| Common synonyms | NMN; β-nicotinamide mononucleotide | β form is commonly studied |
As a commercial ingredient, nicotinamide mononucleotide is commonly supplied as a powder or capsule. Its stability depends on temperature, moisture, pH, and light exposure. Hydrolytic and thermal degradation can increase over time, so manufacturers and laboratories often store material cold and dry. Purity is typically assessed with chromatographic methods, and identity can be confirmed by mass spectrometry. Published stability data for specific finished products remain limited. More data would help define shelf life under real-world conditions.
Regulatory treatment varies by country. In the United States, NMN has been marketed as a dietary supplement, but the Food and Drug Administration has stated that it is excluded from the dietary supplement definition because it was authorized for investigation as a new drug before being marketed as a supplement. Other jurisdictions may treat it as a novel food, a supplement, or an unapproved drug ingredient. Import and sale rules can therefore differ substantially.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide base with a ribose sugar and a phosphate group. Within cells, NMN sits on the biosynthetic route that recycles nicotinamide back into nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in redox reactions and signaling, enzymes that produce and consume it influence many metabolic processes. The compound is therefore best described as an intermediate rather than a final signaling molecule.
In the canonical salvage pathway, nicotinamide phosphoribosyltransferase, known as NAMPT, transfers a phosphoribosyl group to nicotinamide and releases NMN. A second enzyme, NMN adenylyltransferase, then attaches an adenylyl group to NMN to form NAD+. Alternative routes exist, including a pathway that uses nicotinamide riboside and its phosphorylated forms. The relative contribution of extracellular NMN to intracellular NAD+ pools remains an area of active investigation, and the roles of specific transporters and enzymes are not completely defined.
NMN is present in small amounts in various foods, including certain vegetables, fruits, and milk, though dietary quantities are generally low. Laboratory research often uses synthetic or enzymatically produced NMN. The compound has drawn interest because NAD+ levels decline with age in some tissues and because restoring NAD+ may affect metabolism in animal models. Whether oral NMN produces meaningful NAD+ increases in humans and whether such changes translate into health benefits are not fully established.
NMN is generally handled as a hygroscopic and light-sensitive solid in laboratory settings. Recommended storage is typically at -20°C or below, often under desiccation and protected from light. Aqueous solutions are less stable than the solid and may degrade through hydrolysis or other pathways, so fresh preparation is common for analytical work. Repeated freeze-thaw cycles can reduce sample integrity. Stability depends on pH, temperature, buffer composition, and the presence of metal ions, so specific shelf-life values should be determined experimentally rather than assumed.
Quality control for NMN samples often includes purity determination by HPLC, identity confirmation by mass spectrometry or NMR, and water content measurement by Karl Fischer titration. Certificates of analysis may report residual solvents, heavy metals, and microbial limits depending on the intended use. Purity values are method-dependent, so a stated percentage should be interpreted alongside the analytical procedure and detection wavelength. Reference standards help ensure that retention times and spectral data are comparable across laboratories. Researchers increasingly request independent verification because supply chains for specialty chemicals can vary in documentation.
Chemically, NMN is described by the molecular formula C11H15N2O8P and a molecular mass near 334.22 g/mol. The beta anomer has a CAS Registry Number of 1094-61-7. It is typically supplied as a white to off-white powder for laboratory use. The molecule carries a phosphate group and a positively charged nicotinamide ring, giving it polar and water-soluble character. These properties influence how it is detected, purified, and stored in research and analytical laboratories.
Nicotinamide mononucleotide, abbreviated NMN, is a nucleotide composed of nicotinamide, ribose, and phosphate. Its structure links nicotinamide to D-ribose 5-phosphate through a glycosidic bond, placing it in the pyridine nucleotide family. The compound exists in alpha and beta anomeric forms, and the beta form is the one used in NAD+ biosynthesis. NMN is not a protein or a hormone; it is a small water-soluble molecule that occurs in living cells as a metabolic intermediate.
Natural sources of NMN include mammals, plants, and microorganisms, where it functions as an intermediate in NAD+ salvage and biosynthesis pathways. In mammals, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferase. Some foods contain measurable NMN, but reported amounts vary widely by species, tissue, and analytical method. The extent to which dietary NMN contributes to cellular NAD+ pools remains an open research question.
To enable fast and efficient transduction of electrical signals in the nervous system, certain neuronal axons are covered with myelin sheaths. Myelin is a multilamellar membrane that enwraps the axon in segments separated by intervals known as nodes of Ranvier. It is produced by specialized cells: Schwann cells exclusively in the peripheral nervous system, and oligodendrocytes exclusively in the central nervous system. Myelin sheath reduces membrane capacitance and increases membrane resistance in the inter-node intervals, thus allowing a fast, saltatory movement of action potentials from node to node. Myelination is found mainly in vertebrates, but an analogous system has been discovered in a few invertebrates, such as some species of shrimp. Not all neurons in vertebrates are myelinated; for example, axons of the neurons comprising the autonomic nervous system are not, in general, myelinated. Myelin prevents ions from entering or leaving the axon along myelinated segments. As a general rule, myelination increases the conduction velocity of action potentials and makes them more energy-efficient. Whether saltatory or not, the mean conduction velocity of an action potential ranges from 1 meter per second (m/s) to over 100 m/s, and, in general, increases with axonal diameter. Action potentials cannot propagate through the membrane in myelinated segments of the axon. However, the current is carried by the cytoplasm, which is sufficient to depolarize the first or second subsequent node of Ranvier.
Fibrinogen gamma chain, also known as the fibrinogen gamma gene (FGG), is a human gene found on chromosome 3. The protein encoded by this gene is the gamma component of fibrinogen, a blood-borne glycoprotein composed of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia and thrombophilia. Alternative splicing of the mRNA chain results in two transcript variants; the common γA chain and the alternatively spliced γ' chain. Approximately 10% of the total plasma fibrinogen consists of γA/γ' fibrinogen, with <1% consisting of γ'/γ' fibrinogen. Increased and decreased levels of γA/γ' fibrinogen have been associated with coronary artery disease and deep vein thrombosis respectively. In the lung parenchyma of smokers, upregulation of FGG transcript levels has been reported.
Claremont and Miller's Wolverine (1982) introduces the motif that Wolverine emulates samurai ethics and practices to control and humanize his violent impulses and abilities. While he is able to master samurai fighting styles and some norms of behavior, he is not able to fully integrate himself into Japanese society. Comics scholar Jim Davis points out that Claremont took his knowledge of samurai culture from James Clavell's novel Shogun (1975), which takes place in the 16th century; Claremont has confirmed he was inspired by the 1980 TV adaptation. Davis believes that Claremont's depiction of Japanese society seems fixed in the feudal era, which he indicates is problematic. Academic Eric Sobel argues that Wolverine's samurai proficiency is an example of cultural appropriation and that his Japanese supporting characters are highly stereotyped. However, fellow academic Andrew Deman contests Sobel's argument, particularly his omission of Yukio, who is a complex Japanese character and counterpart to Wolverine. Larry Hama, whose Wolverine stories returned the title character to Japan and acted as a sequel to the Claremont–Miller miniseries, credited the influence of Yakuza films and Ridley Scott's Black Rain (1989) as inspiration. Being a Japanese American, Hama believed that his depiction of Japan was more authentic than previous American superhero stories set in the country. Tsutomu Nihei, a Japanese manga artist, created his own interpretation of Wolverine in the miniseries Wolverine: Snikt! (2003).
Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino group-containing sugar. The term can also refer more generally to any organic molecule that contains amino sugar substructures. Aminoglycoside antibiotics display bactericidal activity against Gram-negative aerobes and some anaerobic bacilli where resistance has not yet arisen but generally not against Gram-positive and anaerobic Gram-negative bacteria. Streptomycin is the first-in-class aminoglycoside antibiotic. It is derived from Streptomyces griseus and is the earliest modern agent used against tuberculosis. Streptomycin lacks the common 2-deoxystreptamine moiety (image right, below) present in most other members of this class. Other examples of aminoglycosides include the deoxystreptamine-containing agents kanamycin, tobramycin, gentamicin, and neomycin (see below).
Sources: en.wikipedia.org
Florey returned to the UK in October 1944, collecting his children from Fulton while en route. He was created a Knight Bachelor on 8 June 1944, and invested by King George VI at Buckingham Palace on 4 July 1944. He shared the Nobel Prize in Physiology or Medicine in 1945 with Chain and Fleming. Fleming first observed the antibiotic properties of the mould that makes penicillin, but it was Chain and Florey who developed it into a useful treatment. Isolation of the active compound from the mould depended crucially on Heatley's technical contributions, and for his part, he was awarded an honorary Doctorate of Medicine by Oxford University in 1990. Florey maintained that the penicillin project was originally driven by scientific interests, and that the medicinal discovery was a bonus. The neuroscientist W. Maxwell Cowan observed that: Fleming was the first person Florey saved. Without Florey's work he would have gone down as a somewhat eccentric microbiologist. Florey always insisted that the development of penicillin was a team effort and that he received more credit than he deserved, but the team itself was his creation. The philanthropist Lord Nuffield offered Florey £50,000 (equivalent to £1,866,000 in 2025) as a personal gift; Florey asked him instead to use it to establish research fellowships at the Sir William Dunn School. The first beneficiaries included Abraham, Heatley and Sanders.
Protactinium (91Pa) has no stable isotopes. As 231Pa occurs in usable quantity, and comprises virtually all of the element, it defines the standard atomic weight. Thirty radioisotopes of protactinium have been characterized, ranging from 210Pa to 239Pa. The most stable isotopes are 231Pa with a half-life of 32,700 years, 233Pa with a half-life of 26.975 days, and 230Pa with a half-life of 17.4 days. All of the remaining radioactive isotopes have half-lives less than 1.6 days, and the majority of these have half-lives less than 1.8 seconds. This element also has five meta states, 217mPa (t1/2 1.15 milliseconds), 220m1Pa (t1/2 = 308 nanoseconds), 220m2Pa (t1/2 = 69 nanoseconds), 229mPa (t1/2 = 420 nanoseconds), and 234mPa (t1/2 = 1.16 minutes). The only naturally occurring isotopes are 231Pa, 233Pa, 234Pa, and 234mPa. The first occurs as an intermediate decay product of 235U, the second of (rare) 237Np, and the last two as intermediate decay products of 238U. 231Pa dominates solely because of its longer life. The primary decay mode for protactinium isotopes lighter than (and including) the most stable isotope 231Pa is alpha decay to isotopes of actinium, except 228Pa to 230Pa, which primarily decay by electron capture to isotopes of thorium. The primary mode for the heavier isotopes is beta minus (β−) decay to isotopes of uranium.
In 2000, the World Health Organization redefined "carcinoid", but this new definition has not been accepted by all practitioners. This has led to some complexity in distinguishing between carcinoid and other neuroendocrine tumors in the literature. According to the American Cancer Society, the 2000 WHO definition states: The WHO now divides these growths into neuroendocrine tumors and neuroendocrine cancers. Neuroendocrine tumors are growths that look benign but that might possibly be able to spread to other parts of the body. Neuroendocrine cancers are abnormal growths of neuroendocrine cells which can spread to other parts of the body.
Sources: en.wikipedia.org
Liquid chromatography with tandem mass spectrometry is common because it can quantify low levels of NMN in complex samples. High-performance liquid chromatography with ultraviolet detection is used for simpler purity checks. Nuclear magnetic resonance can confirm identity and detect some impurities.
Solid NMN is typically kept desiccated at −20 °C or below and protected from light. Sealed containers reduce moisture exposure, which can promote degradation. Aqueous solutions are generally less stable and are often prepared fresh.
Important checks include identity confirmation, purity assay, moisture, heavy metals, residual solvents, and microbial contamination. A certificate of analysis should list the methods used and the specification limits. Independent testing can help verify supplier claims.
NMN is nicotinamide mononucleotide, a nucleotide intermediate in the NAD+ salvage pathway. Cells use it to help regenerate NAD+, a coenzyme involved in energy metabolism and cellular signaling. It is present naturally in many organisms and is also produced synthetically for research and consumer products.